EN Mobile Logo

Search form


T2 Diabetes

Alternative and Complementary Medicine for Diabetes

Although information on the safety and efficacy of CAM is a murky area full of conflicting, inconclusive evidence, certain types of CAM do hold promise, and may deserve consideration.

© luminaimages/Shutterstock.com


T2 Diabetes

Our March list includes Testosterone Trials results, self-management in patients transitioning to adult care, and cancer mortality risk with diabetes.

Research has shown the beneficial effects of empagliflozin on all-cause and CV mortality. Does the same hold true for another SGLT2 inhibitor?

How would you treat glucose excursions in a patient treated with prednisone?

Our February list includes a newly approved drug combo, the ADA’s position statement on diabetic retinopathy, and lifestyle intervention studies.

The Qatar Study investigated the efficacy of exenatide plus pioglitazone versus basal-bolus insulin in poorly-controlled type 2 diabetes.

Strength training can improve glycemic control among diabetics, but can it reduce rates of type 2 diabetes and cardiovascular disease?

March news includes a possible biomarker for diabetes, a new sensor to read glucose levels, and a study on insulin resistance and bone fracture.


Subscribe to T2 Diabetes on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.